Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study

To assess the clinical benefit and actionability of molecular targets for genome targeted cancer drugs recommended for clinical practice by the National Comprehensive Cancer Network (NCCN).